Anduril is said Secures $100 Billion in Latest Funding Round
Anduril is said secured $100 billion in its latest funding round, adding another data point to the Healthcare & Life Sciences funding market.
Anduril is said Raises $100 billion in Funding
Anduril is said to seek $100B valuation in latest funding round (PPA:NYSEARCA).
Investors Behind the Funding
The round was backed by experts across the market. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.
Company Profile and Market Context
Anduril is said operates in Healthcare & Life Sciences. Anduril is said's financing adds to recent private-market activity.
Strategic Use of Funds
Seek $100B valuation in latest funding round (PPA:NYSEARCA).
Looking Ahead
Anduril is said to seek $100B valuation in latest funding round (PPA:NYSEARCA)
Source reference: original announcement/article.
View Anduril is said's full profile and funding history on Capvizr →